Clinical Trial

Gut Microbiota of Preterm Infants and Full-term Infants at Early Life

Recruiting
View on ClinicalTrials.gov →
Summary
The aim of this study is to obtain a longitudinal view of the gut microbial establishment of a cohort of 51 preterm (PT) infants compared to 50 full-term (FT) infants from birth to 90 days of age, and to identify key clinical factors that affect the establishment of neonatal microbiome. The hypothesis of the investigators is that the gut microbiota progression of PT group and FT group is different in diversity and composition. Antibiotics and its usage duration is likely the main factor disturbing the colonization and development of the gut microbiome of PT infants.
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2017-12-11; most recent amendment 2024-04-16.
Trial Details
NCT Number NCT03373721
Lead Sponsor Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Conditions Preterm Infant, Gut Microbiome
Enrollment 102 participants
Start Date 2014-07-20
Primary Completion 2026-11-01 (estimated)
Study Completion 2028-12-20 (estimated)
Updated on ClinicalTrials.gov 2024-04-17